{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:47:56Z","timestamp":1794732476790,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68355-x","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:02:39Z","timestamp":1771236159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Machine learning-predicted insulin resistance is a risk factor for 12 types of cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-5644","authenticated-orcid":false,"given":"Chia-Lin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0152-3668","authenticated-orcid":false,"given":"Tomohide","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9730-0605","authenticated-orcid":false,"given":"Wei-Ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4827-6404","authenticated-orcid":false,"given":"Toshimasa","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Yanagimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9799-7975","authenticated-orcid":false,"given":"Yuta","family":"Hiraike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"68355_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223 (2018).","journal-title":"Physiol. Rev."},{"key":"68355_CR2","doi-asserted-by":"publisher","first-page":"e52036","DOI":"10.1371\/journal.pone.0052036","volume":"7","author":"KB Gast","year":"2012","unstructured":"Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A. & Dekkers, O. M. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE 7, e52036 (2012).","journal-title":"PLoS ONE"},{"key":"68355_CR3","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.2337\/dc20-0204","volume":"43","author":"S Ling","year":"2020","unstructured":"Ling, S. et al. Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people. Diab. Care 43, 2313\u20132322 (2020).","journal-title":"Diab. Care"},{"key":"68355_CR4","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.2337\/db20-0084","volume":"69","author":"S Yuan","year":"2020","unstructured":"Yuan, S. et al. Is type 2 diabetes causally associated with cancer risk? Evidence from a two-sample Mendelian randomization study. Diabetes 69, 1588\u20131596 (2020).","journal-title":"Diabetes"},{"key":"68355_CR5","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E. & Ioannidis, J. P. A. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350, g7607\u2013g7607 (2015).","journal-title":"BMJ"},{"key":"68355_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. & Zwahlen, M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569\u2013578 (2008).","journal-title":"Lancet"},{"key":"68355_CR7","doi-asserted-by":"publisher","first-page":"e1003706","DOI":"10.1371\/journal.pmed.1003706","volume":"18","author":"M Vithayathil","year":"2021","unstructured":"Vithayathil, M. et al. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: a mendelian randomisation study. PLoS Med. 18, e1003706 (2021).","journal-title":"PLoS Med."},{"key":"68355_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body fatness and cancer-viewpoint of the IARC working group. N. Engl. J. Med. 375, 794\u2013798 (2016).","journal-title":"N. Engl. J. Med."},{"key":"68355_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","volume":"20","author":"EJ Gallagher","year":"2020","unstructured":"Gallagher, E. J. & LeRoith, D. Hyperinsulinaemia in cancer. Nat. Rev. Cancer 20, 629\u2013644 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"68355_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten, F. R. & Grivennikov, S. I. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51, 27\u201341 (2019).","journal-title":"Immunity"},{"key":"68355_CR11","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti, K. G. M. M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640\u20131645 (2009).","journal-title":"Circulation"},{"key":"68355_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cam4.4912","volume":"12","author":"M Winn","year":"2023","unstructured":"Winn, M. et al. Metabolic dysfunction and obesity-related cancer: results from the cross-sectional National Health and Nutrition Examination Survey. Cancer Med. 12, 606\u2013618 (2023).","journal-title":"Cancer Med."},{"key":"68355_CR13","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/cncr.35235","volume":"130","author":"L Deng","year":"2024","unstructured":"Deng, L. et al. The association of metabolic syndrome score trajectory patterns with risk of all cancer types. Cancer 130, 2150\u20132159 (2024).","journal-title":"Cancer"},{"key":"68355_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/met.2008.0065","volume":"7","author":"P Pothiwala","year":"2009","unstructured":"Pothiwala, P., Jain, S. K. & Yaturu, S. Metabolic syndrome and cancer. Metab. Syndr. Relat. Disord. 7, 279\u2013288 (2009).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"68355_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/MCG.0b013e3182a030c4","volume":"48","author":"R Jinjuvadia","year":"2014","unstructured":"Jinjuvadia, R., Patel, S. & Liangpunsakul, S. The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. J. Clin. Gastroenterol. 48, 172\u2013177 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"68355_CR16","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/dc12-0336","volume":"35","author":"K Esposito","year":"2012","unstructured":"Esposito, K., Chiodini, P., Colao, A., Lenzi, A. & Giugliano, D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diab. Care 35, 2402\u20132411 (2012).","journal-title":"Diab. Care"},{"key":"68355_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12020-013-9973-3","volume":"45","author":"K Esposito","year":"2014","unstructured":"Esposito, K. et al. Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine 45, 28\u201336 (2014).","journal-title":"Endocrine"},{"key":"68355_CR18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","volume":"17","author":"MJ Gunter","year":"2008","unstructured":"Gunter, M. J. et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol. Biomark. Prev. 17, 921\u2013929 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"68355_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/0008-5472.CAN-07-2946","volume":"68","author":"MJ Gunter","year":"2008","unstructured":"Gunter, M. J. et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res. 68, 329\u2013337 (2008).","journal-title":"Cancer Res."},{"key":"68355_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"68355_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora, E. et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diab. Care 23, 57\u201363 (2000).","journal-title":"Diab. Care"},{"key":"68355_CR22","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","volume":"287","author":"MC St\u00fchlinger","year":"2002","unstructured":"St\u00fchlinger, M. C. et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287, 1420\u20131426 (2002).","journal-title":"JAMA"},{"key":"68355_CR23","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.eclinm.2023.101934","volume":"58","author":"S-F Tsai","year":"2023","unstructured":"Tsai, S.-F., Yang, C.-T., Liu, W.-J. & Lee, C.-L. Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. EClinicalMedicine 58, 101934 (2023).","journal-title":"EClinicalMedicine"},{"key":"68355_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41588-023-01625-2","volume":"56","author":"A Oliveri","year":"2024","unstructured":"Oliveri, A. et al. Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank. Nat. Genet. 56, 212\u2013221 (2024).","journal-title":"Nat. Genet."},{"key":"68355_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","volume":"139","author":"T McLaughlin","year":"2003","unstructured":"McLaughlin, T. et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann. Intern. Med. 139, 802\u2013809 (2003).","journal-title":"Ann. Intern. Med."},{"key":"68355_CR26","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","volume":"4","author":"P Lopez-Jaramillo","year":"2023","unstructured":"Lopez-Jaramillo, P. et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 4, e23\u2013e33 (2023).","journal-title":"Lancet Healthy Longev."},{"key":"68355_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4678526","volume":"2020","author":"A S\u00e1nchez-Garc\u00eda","year":"2020","unstructured":"S\u00e1nchez-Garc\u00eda, A. et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int. J. Endocrinol. 2020, 4678526 (2020).","journal-title":"Int. J. Endocrinol."},{"key":"68355_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda, L. E., Rodr\u00edguez-Mor\u00e1n, M. & Guerrero-Romero, F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab. Syndr. Relat. Disord. 6, 299\u2013304 (2008).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"68355_CR29","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White, M. C. et al. Age and cancer risk. Am. J. Prev. Med. 46, S7\u2013S15 (2014).","journal-title":"Am. J. Prev. Med."},{"key":"68355_CR30","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41416-019-0721-1","volume":"122","author":"E Laconi","year":"2020","unstructured":"Laconi, E., Marongiu, F. & DeGregori, J. Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br. J. Cancer 122, 943\u2013952 (2020).","journal-title":"Br. J. Cancer"},{"key":"68355_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","volume":"400","author":"KB Tran","year":"2022","unstructured":"Tran, K. B. et al. The global burden of cancer attributable to risk factors, 2010\u201319: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 563\u2013591 (2022).","journal-title":"Lancet"},{"key":"68355_CR32","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ijc.33685","volume":"149","author":"MF Weber","year":"2021","unstructured":"Weber, M. F. et al. Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study. Int. J. Cancer 149, 1076\u20131088 (2021).","journal-title":"Int. J. Cancer"},{"key":"68355_CR33","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","volume":"30","author":"J Pearson-Stuttard","year":"2021","unstructured":"Pearson-Stuttard, J. et al. Type 2 diabetes and cancer: an umbrella review of observational and mendelian randomization studies. Cancer Epidemiol. Biomark. Prev. 30, 1218\u20131228 (2021).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"68355_CR34","first-page":"717","volume":"23","author":"S Pothiawala","year":"2012","unstructured":"Pothiawala, S., Qureshi, A. A., Li, Y. & Han, J. Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control 23, 717\u2013726 (2012).","journal-title":"Cancer Causes Control"},{"key":"68355_CR35","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/1055-9965.EPI-13-0647","volume":"22","author":"JY Tang","year":"2013","unstructured":"Tang, J. Y. et al. Lower skin cancer risk in women with higher body mass index: the Women\u2019s Health Initiative observational study. Cancer Epidemiol. Biomark. Prev. 22, 2412\u20132415 (2013).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"68355_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","volume":"384","author":"K Bhaskaran","year":"2014","unstructured":"Bhaskaran, K. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5\u00b724 million UK adults. Lancet 384, 755\u2013765 (2014).","journal-title":"Lancet"},{"key":"68355_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/jnci\/djx286","volume":"110","author":"D Yu","year":"2018","unstructured":"Yu, D. et al. Overall and central obesity and risk of lung cancer: a pooled analysis. J. Natl. Cancer Inst. 110, 831\u2013842 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"68355_CR38","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ijc.33292","volume":"148","author":"W Zhou","year":"2021","unstructured":"Zhou, W. et al. Causal relationships between body mass index, smoking and lung cancer: univariable and multivariable Mendelian randomization. Int. J. Cancer 148, 1077\u20131086 (2021).","journal-title":"Int. J. Cancer"},{"key":"68355_CR39","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jacl.2017.05.004","volume":"11","author":"X Lin","year":"2017","unstructured":"Lin, X. et al. Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies. J. Clin. Lipido. 11, 1073\u20131081 (2017).","journal-title":"J. Clin. Lipido."},{"key":"68355_CR40","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/sj.bjc.6605264","volume":"101","author":"H Ulmer","year":"2009","unstructured":"Ulmer, H. et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br. J. Cancer 101, 1202\u20131206 (2009).","journal-title":"Br. J. Cancer"},{"key":"68355_CR41","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/0140-6736(92)90730-Q","volume":"339","author":"FS Facchini","year":"1992","unstructured":"Facchini, F. S., Hollenbeck, C. B., Jeppesen, J., Chen, Y. D. & Reaven, G. M. Insulin resistance and cigarette smoking. Lancet 339, 1128\u20131130 (1992).","journal-title":"Lancet"},{"key":"68355_CR42","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ajcn\/87.4.801","volume":"87","author":"A Chiolero","year":"2008","unstructured":"Chiolero, A., Faeh, D., Paccaud, F. & Cornuz, J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am. J. Clin. Nutr. 87, 801\u2013809 (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"68355_CR43","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0195-668X(03)00260-4","volume":"24","author":"M Fr\u00f6hlich","year":"2003","unstructured":"Fr\u00f6hlich, M. et al. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994\/95). Eur. Heart J. 24, 1365\u20131372 (2003).","journal-title":"Eur. Heart J."},{"key":"68355_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/0022034511421200","volume":"91","author":"J Lee","year":"2012","unstructured":"Lee, J., Taneja, V. & Vassallo, R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J. Dent. Res. 91, 142\u2013149 (2012).","journal-title":"J. Dent. Res."},{"key":"68355_CR45","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).","journal-title":"PLoS Med."},{"key":"68355_CR46","doi-asserted-by":"publisher","first-page":"E3673","DOI":"10.1210\/clinem\/dgab295","volume":"106","author":"Y Hiraike","year":"2021","unstructured":"Hiraike, Y., Yang, C. T., Liu, W. J., Yamada, T. & Lee, C. L. FTO obesity variant-exercise interaction on changes in body weight and BMI: the Taiwan Biobank Study. J. Clin. Endocrinol. Metab. 106, E3673\u2013E3681 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68355_CR47","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/eurjpc\/zwae075","volume":"31","author":"C-L Lee","year":"2024","unstructured":"Lee, C.-L. et al. Interaction between type 2 diabetes polygenic risk and physical activity on cardiovascular outcomes. Eur. J. Prev. Cardiol. 31, 1277\u20131285 (2024).","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68355-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68355-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68355-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:02:40Z","timestamp":1771236160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68355-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68355"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68355-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CL.L. and WJ.L. are inventors of a filed patent application related to this work, entitled \u201cSYSTEM AND METHOD FOR PREDICTING INSULIN RESISTANCE OR PANCREATIC BETA-CELL FUNCTION AND COMPUTER READABLE MEDIUM THEREOF\u201d (application numbers: 113111331 in Taiwan, 2024-056758 in Japan, and 18\/616,217 in the United States). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1396"}}